JP2013184888A - Covered particle - Google Patents

Covered particle Download PDF

Info

Publication number
JP2013184888A
JP2013184888A JP2012048516A JP2012048516A JP2013184888A JP 2013184888 A JP2013184888 A JP 2013184888A JP 2012048516 A JP2012048516 A JP 2012048516A JP 2012048516 A JP2012048516 A JP 2012048516A JP 2013184888 A JP2013184888 A JP 2013184888A
Authority
JP
Japan
Prior art keywords
coating layer
water
soluble
film thickness
particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012048516A
Other languages
Japanese (ja)
Other versions
JP5991573B2 (en
Inventor
Yuta Tsurumaki
鶴巻勇太
Atsunori Miyazaki
宮崎厚徳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NOF Corp
Original Assignee
NOF Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NOF Corp filed Critical NOF Corp
Priority to JP2012048516A priority Critical patent/JP5991573B2/en
Publication of JP2013184888A publication Critical patent/JP2013184888A/en
Application granted granted Critical
Publication of JP5991573B2 publication Critical patent/JP5991573B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

PROBLEM TO BE SOLVED: To provide a covered particle prevented from uneven dissolution and collapse of a covering layer and having long-time sustained releasability caused by regulating the uniformity of the film thickness of the covering layer so as to be in a prescribed level or more.SOLUTION: A covered particle is obtained by covering a core particle having 50-5,000 μm of a median diameter with a hardly water-soluble covering layer containing 1-30 pts.mass of a triacylglycerol having 8-12C fatty acids and 1-30 pts.mass of calcium stearate based on the whole hardly water-soluble covering layer. Further, the covered particle may have a water-soluble covering layer.

Description

本発明は、粉粒体の被覆において、被覆層の膜厚均一性を向上させ、長時間の徐放性を付与した被覆粒子に関する。   The present invention relates to a coated particle that improves the film thickness uniformity of a coating layer and imparts a sustained release property for a long time.

食品、飼料、医薬品、医薬部外品、化粧品などの各分野において、原材料として用いられる粉粒体は、外気や水分、又は相互に接触することによる劣化を防止するために、あるいは流動性の改善、徐放性、マスキング性、溶出防止性、耐酸性などを付与するために、粉粒体を何らかの被膜剤で被覆することが広く行われている。
例えば、食品、飼料、医薬品等の場合、難水溶性又は水に不溶性の被膜剤で粉粒体を被覆することで、粉粒体に消化管内での徐放性を付与することができる。核となる粉粒体が生理活性成分である場合、徐放性の付与により腸内で徐々に溶出させることで生体利用性の向上が期待される。
ここで、徐放性とは「成分を徐々に放出させる性質」の意である。生理活性成分に徐放性がなく摂取後即座に溶解する場合、消化管内での生理活性成分濃度は摂取直後に急上昇した後に短時間で減少し、通常のレベルに戻ってしまう。一方で生理活性成分に徐放性を付与した場合には、生理活性成分が徐々に溶解し、生理活性成分濃度はある一定範囲の濃度を長時間維持することができる。胃及び腸管内での時間あたりの成分の吸収速度には限界があるため、摂取された成分量が同じでも、徐放性を有していた方が吸収される生理活性成分総量は多くなる。
摂取された成分の吸収のほとんどは腸管においてなされる。通常、胃内容物の腸管への移送は食後10分頃から開始し、3〜6時間で十二指腸への移送が完了する。生理活性成分の中には胃酸によるダメージを受けるものあるが、そうした生理活性成分をダメージの少ない状態で腸に移送させ吸収効率を向上させるために、長時間の徐放性が必要となる場合がある。
また、摂取から排泄までに要する時間は24〜36時間程度とされている。このため、生理活性成分の徐放性が長時間にわたりすぎると溶出しきらないままに排泄されてしまう可能性もあるため、完全溶出に要する時間は12〜24時間程度が望ましいと考えられる。
In various fields such as food, feed, pharmaceuticals, quasi-drugs, and cosmetics, the granular materials used as raw materials are used to prevent deterioration due to contact with the outside air, moisture, or with each other, or to improve fluidity. In order to impart sustained release properties, masking properties, elution prevention properties, acid resistance, etc., it is widely practiced to coat the powder particles with some kind of coating agent.
For example, in the case of foods, feeds, pharmaceuticals, and the like, sustained release in the gastrointestinal tract can be imparted to the granules by coating the granules with a slightly water-soluble or water-insoluble coating agent. When the core granular material is a physiologically active ingredient, bioavailability is expected to be improved by gradually elution in the intestine by providing sustained release.
Here, “sustained release” means “a property of gradually releasing components”. When the physiologically active ingredient does not have sustained release and dissolves immediately after ingestion, the concentration of the physiologically active ingredient in the digestive tract rapidly increases immediately after ingestion and then decreases in a short time and returns to the normal level. On the other hand, when sustained release is imparted to the physiologically active ingredient, the physiologically active ingredient is gradually dissolved, and the physiologically active ingredient concentration can be maintained within a certain range for a long time. Since the absorption rate of components per hour in the stomach and intestinal tract is limited, even if the amount of components ingested is the same, the total amount of physiologically active components to be absorbed increases if they have sustained release properties.
Most of the absorption of ingested components is done in the intestine. Usually, the transfer of the stomach contents to the intestinal tract starts about 10 minutes after the meal, and the transfer to the duodenum is completed in 3 to 6 hours. Some bioactive ingredients are damaged by gastric acid, but long-term sustained release may be required to improve the absorption efficiency by transferring such bioactive ingredients to the intestine with little damage. is there.
The time required from ingestion to excretion is about 24 to 36 hours. For this reason, if the sustained release property of the physiologically active ingredient is too long, it may be excreted without being completely eluted, and therefore it is considered that the time required for complete dissolution is preferably about 12 to 24 hours.

粉粒体の被覆技術として、溶融した油脂又は粉末状の油脂で核粒子を被覆する方法や、ゼイン等の含水アルコール可溶タンパク質で粉粒体を造粒被覆する方法(特許文献1)などが知られている。
これらの技術は油脂あるいは難水溶性物質等で核となる粉粒体を造粒被覆することで、核粒子の口腔内あるいは消化管内での溶出を抑制し、不快な味のマスキング効果や徐放性を付与することを目的としている。
上述の従来技術は、核となる粉粒体が造粒されながら被覆される工程を有しているため、被覆粒子の膜厚が部位によって異なり、また空隙の多いポーラスで不均一な被覆粒子となる。
これらの被覆粒子が生体内に摂取された場合、被覆粒子周辺の水分により膜厚の薄い部分あるいは空隙周辺部から早期に溶解する。この薄膜部・空隙周辺部の溶解が引き金となり、被覆粒子全体が早期に溶出してしまい、長時間の徐放性付与が困難である。
このため、従来技術では生理活性成分の効果を継続して発揮させたい場合、一日の間で複数回に分けた摂取が必要となり、摂取者にとって負担となる。
また、生理活性成分の中には酸性条件下で変質・劣化するものもあり、これらの生理活性成分の従来技術による被覆では、胃内で早期に溶解することで腸に移送される前に変質・劣化してしまい、当該生理活性効果を十分に発揮させることは困難であった。
As a powder coating technique, there are a method of coating core particles with molten oil or powdered fat, a method of granulating and coating powder with water-containing alcohol-soluble protein such as zein (Patent Document 1), etc. Are known.
These technologies granulate and coat the core powder with fats and oils or poorly water-soluble substances to suppress elution of the core particles in the oral cavity or digestive tract, masking an unpleasant taste and sustained release. The purpose is to give sex.
Since the above-mentioned conventional technology has a process in which the core powder is coated while being granulated, the film thickness of the coated particles varies depending on the part, and the porous and non-uniform coated particles with many voids Become.
When these coated particles are taken into the living body, they are dissolved early from the thin part of the film or from the peripheral part of the voids by the moisture around the coated particle. The dissolution of the thin film portion and the peripheral portion of the void triggers the entire coated particle to elute early, making it difficult to impart sustained release properties for a long time.
For this reason, in the prior art, when it is desired to continuously exert the effect of the physiologically active ingredient, it is necessary to ingest several times a day, which is a burden on the ingestor.
In addition, some bioactive ingredients may be altered or deteriorated under acidic conditions, and these bioactive ingredients may be altered by the prior art coating before being transported to the intestines by early dissolution in the stomach. -It deteriorated and it was difficult to fully exhibit the said bioactivity effect.

ステアリン酸カルシウムは、錠剤打錠時の離型目的で滑沢剤として汎用されるものであり、また、錠剤のフィルムコートや糖衣工程時の錠剤同士の付着・合一防止目的でも使用される(特許文献2)。しかし、より小さな粒径の被覆粒子の被覆層に合一防止目的で含有させる技術は報告されていない。
上述のステアリン酸カルシウムによる錠剤打錠時の離型作用は、ステアリン酸カルシウム自体の物質同士の結合・付着を妨げる作用によるものであるが、本願発明におけるような粒子の被覆層にステアリン酸カルシウムを配合した場合、被覆層中の物質の結合・付着が妨げられ、被覆層の強度が低下するおそれがある。このため、従来はステアリン酸カルシウムの添加により被覆粒子同士の付着・合一防止と被覆層の強度維持を両立することができなかった。
Calcium stearate is widely used as a lubricant for the purpose of releasing tablets at the time of tableting, and it is also used for the purpose of preventing adhesion and coalescence of tablets during film coating and sugar coating processes (patented) Reference 2). However, no technique has been reported for inclusion in the coating layer of coated particles having a smaller particle size for the purpose of preventing coalescence.
The above-mentioned mold release action at the time of tableting with calcium stearate is due to the action of hindering the binding / adhesion of substances of calcium stearate itself, but when calcium stearate is blended in the particle coating layer as in the present invention The bonding and adhesion of substances in the coating layer may be hindered and the strength of the coating layer may be reduced. For this reason, conventionally, the addition of calcium stearate could not achieve both adhesion and coalescence prevention of the coated particles and maintenance of the strength of the coating layer.

特許文献1には、ゼイン等の含水アルコール可溶性タンパク質による、造粒物の被覆技術が開示されていて、被膜溶液中の、可溶性タンパク質の均一溶解分散性を高めるために、グリセリン脂肪酸エステル等の可塑剤を用いる技術が記載されている。可塑剤は、被膜の柔軟性や被膜強度を向上させる目的で被膜溶液に添加されるものでもあるが、粒子同士の付着抑制を目的として使用されるものではない。特許文献1では、元来が核粒子を造粒させながら被覆する技術のため、粒子同士の付着・合一は大きな問題とならない。しかし、粒子同士の付着・合一が起こってしまうと、工程中の解砕やそれに伴う被膜のはがれにより被覆層の膜厚均一性が損なわれてしまうため、特許文献1のようなグリセリン脂肪酸エステル等の可塑剤の添加によっては、膜厚均一性を向上させ、長時間の徐放性を付与するという本願発明の目的は達成できなかった。   Patent Document 1 discloses a technique for coating a granulated product with a hydrous alcohol-soluble protein such as zein. In order to improve the uniform dissolution and dispersibility of the soluble protein in the coating solution, a plastic such as glycerin fatty acid ester is disclosed. Techniques using agents are described. The plasticizer is also added to the coating solution for the purpose of improving the flexibility and strength of the coating, but is not used for the purpose of suppressing adhesion between particles. In Patent Document 1, the adhesion and coalescence of particles are not a big problem because of the technique of originally coating while granulating the core particles. However, if adhesion and coalescence of particles occur, the uniformity of film thickness of the coating layer is impaired due to crushing during the process and peeling of the coating accompanying it, so glycerin fatty acid ester as in Patent Document 1 Depending on the addition of a plasticizer such as the above, the object of the present invention of improving the film thickness uniformity and imparting long-term sustained release could not be achieved.

特許文献3には、ゼイン又はセラックを溶解した、粒状菓子類のためのコーティング剤の組成が記載され、そのうちの比較例として、中鎖脂肪酸やグリセリン脂肪酸エステルを添加した例が示されている。当該コーティング剤の使用によって、被覆工程中の菓子粒子同士の付着がある程度抑制されることは示されているが、本願発明におけるような粒径の小さな被覆粒子の場合、粒子同士の付着力が強く、特許文献3と同様の方法では粒子同士の付着を防止することはできない。   Patent Document 3 describes the composition of a coating agent for granular confectionery in which zein or shellac is dissolved. As a comparative example, an example in which medium chain fatty acid or glycerin fatty acid ester is added is shown. It has been shown that the use of the coating agent suppresses the adhesion between confectionery particles to some extent during the coating process, but in the case of coated particles with a small particle size as in the present invention, the adhesion between the particles is strong. In the same method as in Patent Document 3, adhesion between particles cannot be prevented.

特開平6−24963号公報JP-A-6-24963 特開2008−24702号公報JP 2008-24702 A 特開平10−108630号公報JP-A-10-108630

本発明が解決しようとする課題は、被覆層の膜厚均一性を一定水準以上にすることで、被覆層の不均一な溶解・崩壊を防止し、長時間の徐放性を有した被覆粒子を提供することにある。   The problem to be solved by the present invention is to prevent the coating layer from being uniformly dissolved and disintegrated by making the coating layer thickness uniformity above a certain level, and to provide coated particles having a long-term sustained release property Is to provide.

本発明者らは上記課題を解決するために鋭意検討した結果、被膜溶液に炭素鎖長8〜12の脂肪酸を有するトリアシルグリセロール及びステアリン酸カルシウムを含有させることが被膜の膜厚均一性向上に大きく寄与することを見出し、本発明を完成させた。
すなわち、本発明は、以下の発明を包含する。
(1)メディアン径50〜5000μmの核粒子を、難水溶性被覆層全量に対し、1〜30質量部の、炭素鎖長8〜12の脂肪酸を有するトリアシルグリセロール、及び、1〜30質量部のステアリン酸カルシウムを含有する難水溶性被覆層で被覆してなる、被覆粒子。
(2)以下に定義する、被覆層の膜厚均一係数が0.2以下である、(1)に記載の被覆粒子。

膜厚均一係数
被覆された1粒子を、長径を通りかつ長径と平行面で割断し、割断面の長径に平行かつ重心点を通る直線A、直線Aと直交する直線B、直線Aと45°に交わる直線C、D、それぞれが通る8点の膜厚の変動係数を測定・算出し、5つの粒子の変動係数の平均を膜厚均一係数と定義する。
(3)さらに、水溶性被覆層を有する、(1)又は(2)に記載の被覆粒子。
(4)難水溶性被覆層の外層に水溶性被覆層があり、さらにその外層に難水溶性被覆層を有する、(3)に記載の被覆粒子。
As a result of intensive studies to solve the above problems, the inventors of the present invention greatly improve the film thickness uniformity of the coating by containing triacylglycerol having a fatty acid having a carbon chain length of 8 to 12 and calcium stearate in the coating solution. We have found that it has contributed and completed the present invention.
That is, the present invention includes the following inventions.
(1) Triacylglycerol having 1 to 30 parts by mass of a fatty acid having a carbon chain length of 8 to 12 and 1 to 30 parts by mass of a core particle having a median diameter of 50 to 5000 μm with respect to the total amount of the hardly water-soluble coating layer Coated particles obtained by coating with a poorly water-soluble coating layer containing calcium stearate.
(2) The coated particle according to (1), wherein the coating layer has a film thickness uniformity coefficient defined below, which is 0.2 or less.

Film thickness uniformity coefficient One coated particle is cleaved by a plane parallel to the major axis and parallel to the major axis of the fractured section, straight line A passing through the center of gravity and straight line B, perpendicular to straight line A, straight line A and 45 ° Are measured and calculated, and the average of the coefficient of variation of the five particles is defined as the film thickness uniformity coefficient.
(3) The coated particles according to (1) or (2), further having a water-soluble coating layer.
(4) The coated particle according to (3), wherein the outer layer of the poorly water-soluble coating layer has a water-soluble coating layer and further has the poorly water-soluble coating layer in the outer layer.

本発明により得られる被覆粒子は、膜厚が均一であるために薄膜部・空隙部からの早期溶出・崩壊を防止することができる。すなわち、被覆層の膜厚均一性を保持させた上で被覆層の膜厚を調整することで、被覆粒子に所望の長時間の徐放性を付与することができる。
この長時間の徐放性により、生体への吸収効率を向上させ、製剤の1日あたりの摂取回数を減らすことができる。
また、酸性条件で変質・劣化してしまう生理活性成分であっても、胃内滞留中の酸性条件での変質・劣化を抑制し、腸に移送後に吸収させることができる。
Since the coated particles obtained by the present invention have a uniform film thickness, they can prevent premature elution / disintegration from the thin film portion / void portion. That is, desired long-term sustained release property can be imparted to the coated particles by adjusting the film thickness of the coating layer while maintaining the film thickness uniformity of the coating layer.
This long-term sustained release can improve the absorption efficiency into the living body and reduce the number of daily intakes of the preparation.
In addition, even a physiologically active component that is altered or deteriorated under acidic conditions can be inhibited after being transferred to the intestine by suppressing alteration or deterioration under acidic conditions during retention in the stomach.

本発明においては、メディアン径50〜5000μmの粒径を有する核粒子を用いる。
平均粒径が50μmより小さい微粉を核粒子とした場合、粒径が小さすぎて良好な被覆粒子とすることができない。また、粒径が5000μmを越えると粉粒体は、工程中に荷重により欠損が生じてしまうため、良好な被覆粒子を得ることができない。核粒子の粒径は、好ましくは100〜2000μm、より好ましくは150〜1000μmである。
核粒子の粒度の測定は、粒径1000μm未満の場合レーザー回折式粒度分布測定装置を用いて行い、粒径1000μm以上の場合篩い分け法を用いて行う。
核粒子は、被覆粒子全体の形態の基礎となるものであり、生理活性成分の有無を問わない。
核粒子を構成する成分としては、製剤用の素材として通常に使用される各種担体物質であればいずれでも良く、例えば、還元パラチノース、セルロース、スクロースなどが例示される。
In the present invention, core particles having a median diameter of 50 to 5000 μm are used.
When a fine powder having an average particle size of less than 50 μm is used as a core particle, the particle size is too small to make a good coated particle. On the other hand, if the particle size exceeds 5000 μm, the powder particles will be damaged due to the load during the process, and thus good coated particles cannot be obtained. The particle diameter of the core particles is preferably 100 to 2000 μm, more preferably 150 to 1000 μm.
The particle size of the core particles is measured using a laser diffraction particle size distribution measuring device when the particle size is less than 1000 μm, and using a sieving method when the particle size is 1000 μm or more.
The core particle is the basis of the form of the entire coated particle, regardless of the presence or absence of a physiologically active component.
The component constituting the core particle may be any of various carrier substances that are usually used as a raw material for preparations, and examples thereof include reduced palatinose, cellulose, sucrose, and the like.

本発明の被覆粒子は、核粒子上に難水溶性層からなる被覆層、又は難水溶性層と水溶性層との繰り返しからなる複数層を有するものである。
本発明における難水溶性被覆層は、常温で難水溶性あるいは水に不溶な、食品のコーティングに用いられる成分を含んでいれば良い。この例としてゼイン、シェラック、グルテン、硬化油脂、脂肪酸金属塩、などが挙げられるが、膜厚均一性を向上させる観点からゼインを用いるのがより好ましい。
ゼインはトウモロコシタンパクの主要成分であり、難水溶性かつ含水アルコール可溶という性質を持つ。溶液濃度を高くできる、良好なフィルム性を持つ、といった理由から、上述のコーティング基材の中でも均一な膜形成に適しているといえる。
ゼインを含水アルコールに溶解する場合、50〜95w/w%、好ましくは60〜80w/w%の含水エタノールに溶解するのが適している。エタノール濃度が高すぎても低すぎてもゼインは溶解しないため、不適である。
難水溶性被覆層は被覆粒子に徐放性を付与する機能を担っており、生理活性成分を含有していても含有していなくても良い。
難水溶性被覆層の合計膜厚は、好ましくは10μm〜500μm、より好ましくは15μm〜100μmである。薄すぎると長時間溶出の効果が得らなかったり、厚すぎると人体に摂取した場合に被覆粒子中に含有させた生理活性成分が有効に溶出する前に体外に排泄されてしまったりするおそれがある。
The coated particle of the present invention has a coating layer composed of a hardly water-soluble layer on the core particle, or a plurality of layers composed of repetitions of a slightly water-soluble layer and a water-soluble layer.
The poorly water-soluble coating layer in the present invention only needs to contain components that are poorly water-soluble at room temperature or insoluble in water and are used for food coating. Examples of this include zein, shellac, gluten, hardened fats and oils, fatty acid metal salts, and the like, but it is more preferable to use zein from the viewpoint of improving the film thickness uniformity.
Zein is a major component of corn protein and has the property of being sparingly water-soluble and soluble in hydrous alcohol. It can be said that it is suitable for forming a uniform film among the above-mentioned coating substrates because it can increase the solution concentration and has good film properties.
When zein is dissolved in hydrous alcohol, it is suitable to dissolve in 50 to 95 w / w%, preferably 60 to 80 w / w% hydrous ethanol. Zein does not dissolve if the ethanol concentration is too high or too low, which is not suitable.
The poorly water-soluble coating layer has a function of imparting sustained release properties to the coated particles, and may or may not contain a physiologically active component.
The total film thickness of the slightly water-soluble coating layer is preferably 10 μm to 500 μm, more preferably 15 μm to 100 μm. If it is too thin, the effect of elution may not be obtained for a long time, and if it is too thick, the physiologically active ingredient contained in the coated particles may be excreted outside the body before it is effectively eluted when ingested by the human body. is there.

本発明における水溶性被覆層は、水溶性被膜剤を含んでいれば良く、水溶性被膜剤としてはカルボキシメチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、ゼラチン、プルラン、キサンタンガム、寒天、カードラン、カラギーナン、アラビアガム、グアーガム、ジェランガム、ペクチン又はアルギン酸ナトリウムなどが挙げられ、なかでもヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロースが好ましい。
水溶性被覆層には、種々の添加剤を含有させることができる。添加剤としては、水溶性色素やグリセリン、アシルグリセロールなどの可塑剤、その他一般に被膜形成に用いられる添加剤を挙げることができる。
水溶性被覆層には、水溶性あるいは水分散性の生理活性成分を含有させることが好ましく、生体内において生理活性成分を放出させる機能を担う。
The water-soluble coating layer in the present invention only needs to contain a water-soluble coating agent. Examples of the water-soluble coating agent include carboxymethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, gelatin, pullulan, xanthan gum, agar, curdlan, carrageenan, Examples include gum arabic, guar gum, gellan gum, pectin, and sodium alginate. Among them, hydroxypropylcellulose and hydroxypropylmethylcellulose are preferable.
Various additives can be contained in the water-soluble coating layer. Examples of the additive include water-soluble dyes, plasticizers such as glycerin and acylglycerol, and other additives generally used for film formation.
The water-soluble coating layer preferably contains a water-soluble or water-dispersible physiologically active component, and has a function of releasing the physiologically active component in vivo.

核粒子、難水溶性被覆層、水溶性被覆層に配合可能な生理活性成分としては、例えばチアミン、リボラビン、ピリドキシン、シアノコバラミン、ナイアシン、葉酸、パントテン酸、ビオチンといった水溶性ビタミン及びこれらの誘導体、アミノ酸、ラクトフェリン、クエン酸、L-カルニチン、コラーゲン、ヒアルロン酸、プロポリス、α-リポ酸、CoQ10、植物抽出物などを挙げることができる。   Examples of physiologically active ingredients that can be incorporated into the core particles, poorly water-soluble coating layers, and water-soluble coating layers include water-soluble vitamins such as thiamine, ribabine, pyridoxine, cyanocobalamin, niacin, folic acid, pantothenic acid, biotin, and derivatives thereof, amino acids , Lactoferrin, citric acid, L-carnitine, collagen, hyaluronic acid, propolis, α-lipoic acid, CoQ10, plant extracts and the like.

核粒子・水溶性被覆層・難水溶性被覆層の上述の機能から、本発明の実施形態としては、以下が可能である。
(1)核粒子−難水溶性被覆層(単層)
(2)核粒子−難水溶性被覆層(複層)
(3)核粒子−水溶性被覆層及び/又は難水溶性被覆層(複層)
(1)〜(3)のいずれにおいても、核粒子及び/又は被覆層中に生理活性成分を含有させることができる。また、当該生理活性成分に徐放性を付与するため、難水溶性被覆層で被覆することが必須である。
好適な実施形態としては、生理活性成分を含有しない核粒子の周囲内層から順に、(a)生理活性成分を含有した水溶性被覆層、(b)難水溶性被覆層、(c)生理活性成分を含有した被覆層、(d)難水溶性被覆層を被覆した徐放性被覆粒子が挙げられる。
別の好適な実施形態としては、生理活性成分を含有した核粒子の周囲内層から順に、(a)難水溶性被覆層、(b)生理活性成分を含有した水溶性被覆層、(c)難水溶性被覆層を被覆した徐放性被覆粒子が挙げられる。
被覆層の数は、上記好適な実施形態に限られず、さらに複層を重ねることも可能である。
From the above functions of the core particle, the water-soluble coating layer, and the poorly water-soluble coating layer, the following is possible as an embodiment of the present invention.
(1) Core particles-poorly water-soluble coating layer (single layer)
(2) Core particles-poorly water-soluble coating layer (multilayer)
(3) Core particle-water-soluble coating layer and / or poorly water-soluble coating layer (multilayer)
In any of (1) to (3), a physiologically active component can be contained in the core particle and / or the coating layer. In addition, in order to impart sustained release properties to the physiologically active ingredient, it is essential to coat it with a slightly water-soluble coating layer.
In a preferred embodiment, in order from the inner peripheral layer of the core particle not containing a physiologically active ingredient, (a) a water-soluble coating layer containing a physiologically active ingredient, (b) a poorly water-soluble coating layer, (c) a physiologically active ingredient And (d) sustained-release coated particles coated with a poorly water-soluble coating layer.
In another preferred embodiment, in order from the inner peripheral layer of the core particle containing the physiologically active ingredient, (a) a slightly water-soluble coating layer, (b) a water-soluble coating layer containing the physiologically active ingredient, (c) difficult Examples include sustained-release coated particles coated with a water-soluble coating layer.
The number of coating layers is not limited to the above-described preferred embodiment, and multiple layers can be stacked.

難水溶性被覆層に含有される炭素鎖長8〜12の脂肪酸を有するトリアシルグリセロールは、例えば、カプリル酸(炭素鎖長8)、カプリン酸(炭素鎖長10)、ラウリン酸(炭素鎖長12)などの脂肪酸と、グリセリンのエステルである、中鎖脂肪酸トリグリセリドが挙げられる。
グリセリンには、エステル結合に寄与し得るヒドロキシル基が3つあることから、脂肪酸の種類及び結合部位により種々のアシルグリセロールが存在する。本発明における炭素鎖長8〜12の脂肪酸を有するトリアシルグリセロールは、この脂肪酸の結合部位を限定するものではない。
炭素鎖長8〜12の脂肪酸を有するトリアシルグリセロールを、本発明における難水溶性被膜に配合することで、被膜の柔軟性・付着性を向上させ、工程中の被膜のはがれを防止し、膜厚の均一な被膜を形成させることができる。
炭素鎖長14以上の長鎖脂肪酸を有するトリアシルグリセロールは、融点が高く、また粘度も高いために被膜の付着性が高くなりすぎ、粒子の合一が起こりやすく、本発明の難水溶性被膜に含有させるには不適である。
Triacylglycerol having a fatty acid having a carbon chain length of 8 to 12 contained in the poorly water-soluble coating layer is, for example, caprylic acid (carbon chain length 8), capric acid (carbon chain length 10), lauric acid (carbon chain length). 12) and the like, and medium-chain fatty acid triglycerides that are esters of glycerin.
Since glycerin has three hydroxyl groups that can contribute to an ester bond, various acylglycerols exist depending on the type of fatty acid and the binding site. The triacylglycerol having a fatty acid having a carbon chain length of 8 to 12 in the present invention does not limit the binding site of this fatty acid.
By adding triacylglycerol having a fatty acid having a carbon chain length of 8 to 12 to the poorly water-soluble coating in the present invention, the flexibility and adhesion of the coating is improved, and peeling of the coating during the process is prevented. A film having a uniform thickness can be formed.
Triacylglycerol having a long chain fatty acid having a carbon chain length of 14 or more has a high melting point and a high viscosity, so that the adhesion of the film becomes too high and the particles are likely to coalesce. It is unsuitable for inclusion in.

ステアリン酸カルシウムは、食品添加物公定書あるいは日本薬局方に記載の基準を満たすものであれば良く、ステアリン酸(炭素鎖長18の脂肪酸)及びパルミチン酸(炭素鎖長16の脂肪酸)を主成分とする高級脂肪酸のカルシウム塩混合物であっても良い。
ステアリン酸カルシウムを本発明における難水溶性被膜に配合することで、工程中の粒子の合一を防止し、被膜の膜厚均一性を向上させることができる。
Calcium stearate only needs to satisfy the standards described in the Food Additives Official Standard or the Japanese Pharmacopoeia, and is mainly composed of stearic acid (a fatty acid having a carbon chain length of 18) and palmitic acid (a fatty acid having a carbon chain length of 16). It may be a calcium salt mixture of higher fatty acids.
By blending calcium stearate into the poorly water-soluble film in the present invention, coalescence of particles during the process can be prevented and the film thickness uniformity of the film can be improved.

難水溶性被覆層中の、炭素鎖長8〜12の脂肪酸を有するトリアシルグリセロールの含有量は、難水溶性被覆層全量に対し1〜30質量%、好ましくは3〜20質量%であり、1質量%より少ないと、膜のはがれを防止する効果が得られず、30質量%より多いと、膜の強度を損ねる傾向となるため好ましくない。
難水溶性被覆層中の、ステアリン酸カルシウムの含有量は、難水溶性被覆層全量に対し1〜30質量%、好ましくは2〜15質量%であり、1質量%より少ないと、工程中の粒子の合一を防止する効果が得られず、30質量%より多いと、膜の付着性及び強度を損ねる傾向となるため好ましくない。
The content of the triacylglycerol having a fatty acid having a carbon chain length of 8 to 12 in the poorly water-soluble coating layer is 1 to 30% by mass, preferably 3 to 20% by mass, based on the total amount of the hardly water-soluble coating layer. If it is less than 1% by mass, the effect of preventing film peeling cannot be obtained, and if it exceeds 30% by mass, the strength of the film tends to be impaired, which is not preferable.
The content of calcium stearate in the poorly water-soluble coating layer is 1 to 30% by mass, preferably 2 to 15% by mass with respect to the total amount of the poorly water-soluble coating layer. The effect of preventing the coalescence of the film cannot be obtained, and if it exceeds 30% by mass, the adhesion and strength of the film tend to be impaired.

本発明において膜厚均一係数とは、膜厚のばらつきを示す指標であり、測定方法は以下のとおりである。
被覆された1粒子を、2片に割断する。割断方法はカミソリ刃を用いても良く、粒径が小さい場合には樹脂への包埋後にミクロトームを用いても良い。電子顕微鏡観察により割断面の長径に平行かつ割断面の重心を通る直線A、直線Aと直交し、割断面の重心を通る直線B、直線A・Bの交点を通り、かつ直線Aと45°に交わる直線C・Dを規定する。直線A・B・C・Dそれぞれが膜と交わる8点の膜厚の標準偏差を測定・算出し、得られた標準偏差を8点の膜厚の平均値で除して変動係数を算出する。膜厚の変動係数の算出法は以下のとおりである。
In the present invention, the film thickness uniformity coefficient is an index indicating variations in film thickness, and the measurement method is as follows.
The coated particle is cut into two pieces. The cleaving method may use a razor blade, and if the particle size is small, a microtome may be used after embedding in a resin. Observed by electron microscope, straight line A parallel to the major axis of the fractured surface and passing through the center of gravity of the fractured surface, perpendicular to the straight line A, passing through the intersection of the straight line B and the straight lines A and B passing through the center of gravity of the fractured surface, and 45 ° with the straight line A A straight line C · D that intersects is defined. Measure and calculate the standard deviation of the film thickness at 8 points where each of the straight lines A, B, C, and D intersects the film, and calculate the coefficient of variation by dividing the obtained standard deviation by the average value of the film thickness at the 8 points. . The calculation method of the variation coefficient of the film thickness is as follows.

Figure 2013184888
Figure 2013184888

得られた変動係数について、5つの粒子の平均を、膜厚均一係数と定義する。
被覆層の被覆が均一になされた被覆粒子は、膜厚均一係数が0.2以下となる。しかし、2粒子以上が合一及び荷重による剥離を繰り返した粒子では、一部の膜厚が極端に薄くあるいは厚くなり、膜圧均一係数は上昇する。こうして膜厚が不均一となった被覆粒子では、膜の一部が早期に溶解してしまい、期待された徐放性を発揮することができない。
For the obtained coefficient of variation, the average of the five particles is defined as the film thickness uniformity coefficient.
The coated particles that are uniformly coated with the coating layer have a film thickness uniformity coefficient of 0.2 or less. However, in the case of particles in which two or more particles are repeatedly coalesced and peeled off by a load, a part of the film thickness becomes extremely thin or thick, and the film pressure uniformity coefficient increases. With the coated particles having a non-uniform film thickness, a part of the film dissolves at an early stage, and the expected sustained release property cannot be exhibited.

本発明で用いられる被覆方法は、通常の流動層造粒機によるもので良く、装置下部からの送風により、流動層を形成している粉粒体に対して被覆液をスプレー噴霧することで、粉粒体周囲に被膜物質を含む被覆液を付着させ、同時に装置下部からの送風により乾燥させることで、被覆層を形成させるものである。スプレー方式としては、トップスプレー、サイドスプレー、タンジェンシャルスプレーなど、いずれでも良い。
ここで流動層とは、粉粒体が装置下部からの均一な送風による浮遊と重力による落下が釣り合い、ある一定範囲の高さで動き回る状態のことを指す。
膜厚均一性の向上のためには、被膜の柔軟性・展延性を向上させるとともに、粒子同士の凝集を防ぐ必要がある。
すなわち、被膜物質はスプレーされて芯物質に付着後、完全に固定化されるのではなく、粒子同士や装置壁への衝突や転動により展延され、より密な被膜となる。この際に被膜物質に柔軟性・展延性が欠けていると、被膜の展延が起こらず、荷重により被膜が剥がれ落ちてしまう。
また、被覆工程で粒子同士の凝集が起こると、一度凝集した粒子が粒子同士又は装置壁への衝突荷重により崩れる際に被膜の剥離をともなってしまい、均一な膜厚を保持することができない。
本発明では、難水溶性被覆層に炭素鎖長8〜12の脂肪酸を有するアシルグリセロールを0.1〜30質量部、及びステアリン酸カルシウムを0.1〜30質量部を同時に含有させることで、被膜物質の展延性の向上・凝集抑制の効果を及ぼし、膜厚の均一性向上に寄与する。
The coating method used in the present invention may be by an ordinary fluidized bed granulator, and by spraying the coating liquid on the granular material forming the fluidized bed by blowing from the lower part of the apparatus, A coating liquid containing a coating substance is attached to the periphery of the granular material and simultaneously dried by blowing from the lower part of the apparatus to form a coating layer. As the spray method, any of top spray, side spray, tangential spray, and the like may be used.
Here, the fluidized bed refers to a state in which the granular material moves in a certain range of height, balanced by floating by uniform air blowing from the lower part of the apparatus and dropping by gravity.
In order to improve the film thickness uniformity, it is necessary to improve the flexibility and spreadability of the coating and to prevent the particles from aggregating.
That is, the coating substance is not sprayed and adhered to the core substance, and is not completely fixed, but is spread by collision or rolling with the particles or the device wall, resulting in a denser coating. At this time, if the coating material lacks flexibility and spreadability, the coating does not spread and the coating peels off due to the load.
Further, when the particles are aggregated in the coating step, once the aggregated particles collapse due to the collision load between the particles or the apparatus wall, the coating is peeled off, and a uniform film thickness cannot be maintained.
In the present invention, 0.1-30 parts by mass of acylglycerol having a fatty acid having a carbon chain length of 8-12 and 0.1-30 parts by mass of calcium stearate are simultaneously contained in the sparingly water-soluble coating layer. It has the effect of improving the spreadability of materials and suppressing aggregation, and contributes to the improvement of film thickness uniformity.

本発明の被覆粒子は、生理活性成分の持続的な放出を必要とする、食品、飼料、医薬品、医薬部外品、動物薬、化粧品などの各分野において、被覆粒子をそのまま、あるいは各種製剤に加工して利用することができる。   The coated particles of the present invention require the sustained release of physiologically active ingredients, and in various fields such as food, feed, pharmaceuticals, quasi drugs, veterinary drugs, cosmetics, etc., the coated particles can be used as they are or in various formulations. Can be used after processing.

以下、実施例により本発明を説明するが、本発明はこれによって限定されるものではない。
以下の記載において、%は特に断らない限り質量基準である。
[実施例1]
パラチニット(還元パラチノース:三井製糖(株)製、粒径16〜22メッシュ)600gを流動層造粒機(フロイント産業(株)製、スパイラフロー)に仕込み、被覆液Aを145g噴霧し、被覆した。その後、被覆液Bを363.2g、被覆液Aを145g、被覆液Bを363.2gの順に噴霧し、被覆した。
被覆液Aの組成は、リボフラビンリン酸エステルNa 4%、ヒドロキシプロピルセルロース(商品名「セルニーL」日本曹達(株)製)2%、水94%、である。
被覆液Bの組成は、ゼイン(商品名「小林ツェインDP」小林香料(株)製)13.5%、中鎖脂肪酸トリグリセリド(商品名「パナセート810」日油(株)製、脂肪酸組成:カプリル酸(炭素鎖長8)85%、カプリン酸(炭素鎖長10)15%)1%、ステアリン酸カルシウム(日油(株)製)0.5%、70%エタノール85%、である。
被覆粒子全体の組成、及び各被覆層の組成を表1に記した。
EXAMPLES Hereinafter, although an Example demonstrates this invention, this invention is not limited by this.
In the following description, “%” is based on mass unless otherwise specified.
[Example 1]
600 g of palatinit (reduced palatinose: Mitsui Sugar Co., Ltd., particle size 16-22 mesh) was charged into a fluidized bed granulator (Freund Sangyo Co., Ltd., Spiraflow), and 145 g of coating liquid A was sprayed to coat. . Thereafter, 363.2 g of coating liquid B, 145 g of coating liquid A, and 363.2 g of coating liquid B were sprayed in this order to coat.
The composition of the coating liquid A is 4% riboflavin phosphate Na, 2% hydroxypropylcellulose (trade name “Selney L” manufactured by Nippon Soda Co., Ltd.), and 94% water.
The composition of the coating liquid B is as follows: zein (trade name “Kobayashi Zein DP” manufactured by Kobayashi Fragrance Co., Ltd.) 13.5%, medium chain fatty acid triglyceride (trade name “Panasate 810” manufactured by NOF Corporation, fatty acid composition: capryl Acid (carbon chain length 8) 85%, capric acid (carbon chain length 10) 15%) 1%, calcium stearate (manufactured by NOF Corporation) 0.5%, 70% ethanol 85%.
Table 1 shows the composition of the entire coated particles and the composition of each coating layer.

[比較例1]
被覆液Bの組成を、ゼイン(商品名「小林ツェインDP」小林香料(株)製)14%、中鎖脂肪酸トリグリセリド(商品名「パナセート810」日油(株)製)1%、70%エタノール85%、とした以外は、実施例1と同様にして被覆粒子を得た。
被覆粒子全体の組成、及び各被覆層の組成を表1に記した。
[比較例2]
被覆液Bの組成を、ゼイン(商品名「小林ツェインDP」小林香料(株)製)10%、中鎖脂肪酸トリグリセリド(商品名「パナセート810」日油(株)製)5%、70%エタノール85%、とした以外は、実施例1と同様にして被覆粒子を得た。
被覆粒子全体の組成、及び各被覆層の組成を表1に記した。
[比較例3]
被覆液Bの組成を、ゼイン(商品名「小林ツェインDP」小林香料(株)製)14.5%、ステアリン酸カルシウム(日油(株)製)0.5%、70%エタノール85%、とした以外は、実施例1と同様にして被覆粒子を得た。
被覆粒子全体の組成、及び各被覆層の組成を表2に記した。
[比較例4]
被覆液Bの組成を、ゼイン(商品名「小林ツェインDP」小林香料(株)製)10%、ステアリン酸カルシウム(日油(株)製)5%、70%エタノール85%、とした以外は、実施例1と同様にして被覆粒子を得た。
被覆粒子全体の組成、及び各被覆層の組成を表2に記した。
[比較例5]
被覆液Bの組成を、ゼイン(商品名「小林ツェインDP」小林香料(株)製)15%、70%エタノール85%、とした以外は、実施例1と同様にして被覆粒子を得た。
被覆粒子全体の組成、及び各被覆層の組成を表2に記した。
[比較例6]
リボフラビンリン酸エステルNa 2.7%、及びデンプン(商品名「パインフロー」松谷化学工業(株)製)97.3%の混合粉末600gを、流動層造粒機(フロイント産業(株)製、スパイラフロー)に仕込み、被覆液705.9g(ゼイン(商品名「小林ツェインDP」小林香料(株)製)15%、70%エタノール85%)を噴霧し、被覆した。
被覆粒子全体の組成を表3に記した。
[Comparative Example 1]
The composition of the coating liquid B is as follows: zein (trade name “Kobayashi Zein DP”, Kobayashi Fragrance Co., Ltd.) 14%, medium chain fatty acid triglyceride (trade name “Panasate 810”, NOF Corporation) 1%, 70% ethanol Coated particles were obtained in the same manner as in Example 1 except that the content was 85%.
Table 1 shows the composition of the entire coated particles and the composition of each coating layer.
[Comparative Example 2]
The composition of the coating liquid B is 10% zein (trade name “Kobayashi Zein DP” manufactured by Kobayashi Fragrance Co., Ltd.), 5% medium chain fatty acid triglyceride (trade name “Panasate 810” manufactured by NOF Corporation), 70% ethanol. Coated particles were obtained in the same manner as in Example 1 except that the content was 85%.
Table 1 shows the composition of the entire coated particles and the composition of each coating layer.
[Comparative Example 3]
The composition of the coating liquid B is as follows: zein (trade name “Kobayashi Zein DP” manufactured by Kobayashi Fragrance Co., Ltd.) 14.5%, calcium stearate (manufactured by NOF Corporation) 0.5%, 70% ethanol 85%, The coated particles were obtained in the same manner as in Example 1 except that.
Table 2 shows the composition of the entire coated particles and the composition of each coating layer.
[Comparative Example 4]
The composition of the coating liquid B was 10% zein (trade name “Kobayashi Zein DP” manufactured by Kobayashi Fragrance Co., Ltd.), 5% calcium stearate (manufactured by NOF Corporation), and 70% ethanol 85%. Coated particles were obtained in the same manner as Example 1.
Table 2 shows the composition of the entire coated particles and the composition of each coating layer.
[Comparative Example 5]
Coated particles were obtained in the same manner as in Example 1 except that the composition of the coating liquid B was 15% zein (trade name “Kobayashi Zein DP” manufactured by Kobayashi Fragrance Co., Ltd.) and 70% ethanol 85%.
Table 2 shows the composition of the entire coated particles and the composition of each coating layer.
[Comparative Example 6]
Riboflavin phosphate Na 2.7% and starch (trade name “Pine Flow” Matsutani Chemical Industry Co., Ltd.) 97.3% mixed powder 600 g, fluidized bed granulator (Freund Sangyo Co., Ltd., Spiral flow) was sprayed and coated with 705.9 g of coating liquid (Zein (trade name “Kobayashi Zein DP”, Kobayashi Fragrance Co., Ltd.) 15%, 70% ethanol 85%).
The composition of the whole coated particle is shown in Table 3.

[膜厚均一係数]
実施例1及び比較例1〜6で得られた被覆顆粒について、粒子を、目視下でカミソリ刃で割断し、電子顕微鏡観察により割断面の長径に平行かつ割断面の重心を通る直線A、直線Aと直交し、割断面の重心を通る直線B、直線A・Bの交点を通り、かつ直線Aと45°に交わる直線C・Dを規定する。直線A・B・C・Dそれぞれが膜と交わる8点の膜厚の変動係数を測定・算出した。5粒子について得られた膜厚の変動係数をもとに、膜厚均一係数を算出した。各粒子の膜厚測定値、膜厚平均値、標準偏差、膜厚の変動係数、膜厚均一係数、平均膜厚について表4・5に記載した。
[平均膜厚]
上記[膜厚均一係数]で測定した8点、5つの粒子についての膜厚の平均とした。
[溶出性試験]
実施例1及び比較例1〜6で得られた被覆顆粒について、日本薬局方溶出試験法に基づき、以下の条件で溶出試験を行った。
溶出液: 日本薬局方崩壊試験法第二液(pH6.8)
試験方法: 日本薬局方溶出試験法パドル法
回転数: 100rpm
温度: 37℃
試験サンプル: リボフラビンリン酸エステルNaとして30mg相当量
測定方法: 自動溶出試験機(波長266nmによる吸光度測定)
[Thickness uniformity coefficient]
About the coated granule obtained in Example 1 and Comparative Examples 1 to 6, the particles were cleaved with a razor blade under visual observation, and the straight line A and straight line parallel to the major axis of the fractured section and passing through the center of gravity of the fractured section by electron microscope observation A straight line C · D that intersects with the straight line B and passes through the intersection of the straight lines A and B perpendicular to A and intersects the straight line A and 45 ° is defined. The coefficient of variation of film thickness at 8 points where the straight lines A, B, C, and D intersect with the film were measured and calculated. The film thickness uniformity coefficient was calculated based on the film thickness variation coefficient obtained for 5 particles. Tables 4 and 5 show the film thickness measurement values, film thickness average values, standard deviation, film thickness variation coefficient, film thickness uniformity coefficient, and average film thickness for each particle.
[Average film thickness]
It was set as the average of the film thickness about 8 points | pieces and 5 particle | grains measured by said [film thickness uniformity coefficient].
[Elution test]
About the coated granule obtained in Example 1 and Comparative Examples 1-6, the elution test was done on condition of the following based on the Japanese Pharmacopoeia elution test method.
Eluent: Japanese Pharmacopoeia Disintegration Test Method Second Solution (pH 6.8)
Test method: Japanese Pharmacopoeia dissolution test paddle method Rotation speed: 100rpm
Temperature: 37 ° C
Test sample: Riboflavin phosphate Na equivalent to 30 mg Measurement method: Automatic dissolution tester (absorbance measurement at a wavelength of 266 nm)

Figure 2013184888
Figure 2013184888

Figure 2013184888
Figure 2013184888

Figure 2013184888
Figure 2013184888

Figure 2013184888
Figure 2013184888

Figure 2013184888
Figure 2013184888

表4より、難水溶性被覆層に、炭素鎖長8〜12の脂肪酸を有するトリアシルグリセロール及びステアリン酸カルシウムを含有させた実施例1では、膜厚が均一であり良好な溶出性能を有する被覆顆粒が得られたことがわかる。溶出試験3時間経過時点及び12時間経過時点でも完全溶出しておらず、長時間の徐放性を有することがわかる。   From Table 4, in Example 1 in which a triacylglycerol having a fatty acid having a carbon chain length of 8 to 12 and calcium stearate were contained in a slightly water-soluble coating layer, the coated granule having a uniform film thickness and good elution performance It turns out that was obtained. It can be seen that even after 3 hours and 12 hours have passed, the dissolution test does not completely dissolve and has a sustained release property for a long time.

比較例1では、難水溶性被覆層にステアリン酸カルシウムを含有していない。平均膜厚は実施例1とほぼ同じであるが膜厚均一係数は0.29と高めであり、不均一な被覆層を有しており、長時間の徐放性は実施例1に比べ劣っている。
比較例2では、難水溶性被覆層にステアリン酸カルシウムを含有せず、トリアシルグリセロールを33.3%含有しているが、ステアリン酸カルシウムを含有せず、多すぎるトリアシルグリセロールを含有することにより、被覆層が不均一かつ脆弱となり、長時間の徐放性を有していない。
表5より、難水溶性被覆層に、ステアリン酸カルシウムを33.33%含有し、炭素鎖長8〜12の脂肪酸を有するトリアシルグリセロールを含有しない比較例3では、被覆層の展延性・柔軟性が低く不均一な被覆層となり、長時間の徐放性を有していない。
比較例4では、難水溶性被覆層に、炭素鎖長8〜12の脂肪酸を有するトリアシルグリセロールを33.3%含有しているが、多すぎるアシルグリセロールにより工程中での被覆粒子相互の付着・合一と解砕が多く見られ、不均一な被覆層となり長時間の徐放性を有していない。
比較例5では、難水溶性被覆層中に、炭素鎖長8〜12の脂肪酸を有するトリアシルグリセロール及びステアリン酸カルシウム両方を含有していないが、被覆層の展延性・柔軟性が低く、また粒子の付着・合一と解砕による不均一な被覆層となり、長時間の徐放性を有していない。
表3の、従来技術による比較例6では、溶出試験3時間経過時点で、すでに完全溶出してしまっており、長時間の徐放性を有していない。

In Comparative Example 1, the poorly water-soluble coating layer does not contain calcium stearate. The average film thickness is almost the same as in Example 1, but the film thickness uniformity coefficient is as high as 0.29, has a non-uniform coating layer, and the long-term sustained release is inferior to that in Example 1. ing.
In Comparative Example 2, the poorly water-soluble coating layer does not contain calcium stearate and contains 33.3% triacylglycerol, but does not contain calcium stearate and contains too much triacylglycerol, The coating layer becomes uneven and brittle, and does not have long-term sustained release properties.
From Table 5, in Comparative Example 3 containing 33.33% calcium stearate and containing no triacylglycerol having a fatty acid having a carbon chain length of 8 to 12 in the poorly water-soluble coating layer, the spreadability and flexibility of the coating layer Is a low and non-uniform coating layer and does not have a prolonged release property.
In Comparative Example 4, the poorly water-soluble coating layer contains 33.3% of triacylglycerol having a fatty acid having a carbon chain length of 8 to 12, but too much acylglycerol causes adhesion between coated particles in the process.・ Much coalescence and crushing are observed, resulting in a non-uniform coating layer and no prolonged release.
In Comparative Example 5, the poorly water-soluble coating layer does not contain both triacylglycerol and calcium stearate having a fatty acid having a carbon chain length of 8 to 12, but the coating layer has low spreadability and flexibility, and particles It becomes a non-uniform coating layer due to adhesion, coalescence and crushing of the material, and does not have a sustained release property for a long time.
In Comparative Example 6 of Table 3 according to the prior art, the elution test has already been completely dissolved at the time point of 3 hours, and does not have a long-term sustained release property.

Claims (4)

メディアン径50〜5000μmの核粒子を、難水溶性被覆層全量に対し、1〜30質量部の、炭素鎖長8〜12の脂肪酸を有するトリアシルグリセロール、及び、1〜30質量部のステアリン酸カルシウムを含有する難水溶性被覆層で被覆してなる、被覆粒子。   1 to 30 parts by mass of triacylglycerol having a fatty acid having a carbon chain length of 8 to 12 and 1 to 30 parts by mass of calcium stearate with respect to the total amount of the hardly water-soluble coating layer. Coated particles obtained by coating with a poorly water-soluble coating layer containing 以下に定義する、被覆層の膜厚均一係数が0.2以下である、請求項1に記載の被覆粒子。

膜厚均一係数
被覆された1粒子を、長径を通りかつ長径と平行面で割断し、割断面の長径に平行かつ重心点を通る直線A、直線Aと直交する直線B、直線Aと45°に交わる直線C、D、それぞれが通る8点の膜厚の変動係数を測定・算出し、5つの粒子の変動係数の平均を膜厚均一係数と定義する。
The coated particles according to claim 1, wherein the coating layer has a film thickness uniformity coefficient defined below, which is 0.2 or less.

Film thickness uniformity coefficient One coated particle is cleaved by a plane parallel to the major axis and parallel to the major axis of the fractured section, straight line A passing through the center of gravity and straight line B, perpendicular to straight line A, straight line A and 45 ° Are measured and calculated, and the average of the coefficient of variation of the five particles is defined as the film thickness uniformity coefficient.
さらに、水溶性被覆層を有する、請求項1又は2に記載の被覆粒子。   The coated particle according to claim 1, further comprising a water-soluble coating layer. 難水溶性被覆層の外層に水溶性被覆層があり、さらにその外層に難水溶性被覆層を有する、請求項3に記載の被覆粒子。
The coated particle according to claim 3, wherein the outer layer of the poorly water-soluble coating layer has a water-soluble coating layer, and further has the poorly water-soluble coating layer in the outer layer.
JP2012048516A 2012-03-05 2012-03-05 Coated particles Active JP5991573B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2012048516A JP5991573B2 (en) 2012-03-05 2012-03-05 Coated particles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2012048516A JP5991573B2 (en) 2012-03-05 2012-03-05 Coated particles

Publications (2)

Publication Number Publication Date
JP2013184888A true JP2013184888A (en) 2013-09-19
JP5991573B2 JP5991573B2 (en) 2016-09-14

Family

ID=49386651

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012048516A Active JP5991573B2 (en) 2012-03-05 2012-03-05 Coated particles

Country Status (1)

Country Link
JP (1) JP5991573B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018095566A (en) * 2016-12-08 2018-06-21 アサヒグループ食品株式会社 Water-soluble functional raw material-containing composition, soft capsule, and degradation inhibiting method of water-soluble functional raw material in soft capsule

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5949840A (en) * 1982-09-14 1984-03-22 Taiyo Yakuhin Kogyo Kk Prevention of sticking of granule and fine particle
JPH0347523A (en) * 1989-07-12 1991-02-28 Nippon Oil & Fats Co Ltd Coating method of solid particles and coated material
JP2008539777A (en) * 2005-05-18 2008-11-20 ディーエスエム アイピー アセッツ ビー.ブイ. Composition for enteral administration of microorganisms
JP2009084157A (en) * 2007-09-27 2009-04-23 Nof Corp Method for producing oil and fat-coated powder

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5949840A (en) * 1982-09-14 1984-03-22 Taiyo Yakuhin Kogyo Kk Prevention of sticking of granule and fine particle
JPH0347523A (en) * 1989-07-12 1991-02-28 Nippon Oil & Fats Co Ltd Coating method of solid particles and coated material
JP2008539777A (en) * 2005-05-18 2008-11-20 ディーエスエム アイピー アセッツ ビー.ブイ. Composition for enteral administration of microorganisms
JP2009084157A (en) * 2007-09-27 2009-04-23 Nof Corp Method for producing oil and fat-coated powder

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018095566A (en) * 2016-12-08 2018-06-21 アサヒグループ食品株式会社 Water-soluble functional raw material-containing composition, soft capsule, and degradation inhibiting method of water-soluble functional raw material in soft capsule

Also Published As

Publication number Publication date
JP5991573B2 (en) 2016-09-14

Similar Documents

Publication Publication Date Title
JP6581649B2 (en) Formulation containing particles
JP2015500241A (en) Sustained release composition based on amphiphilic lipids
JP2015512945A (en) Soft elastic capsule containing tablet and liquid or semi-solid filler, and method for producing the same
JP5102401B1 (en) Large intestine specific disintegration capsule
KR102638203B1 (en) Arimoclomol formulation
EP3188713B2 (en) Method of inducing satiety
EP3338804B1 (en) Enteric capsule
JP2015172070A (en) Film coating composition from solid powder compounds
JP2004123636A (en) Doubly coated granule and method for producing the same
WO2007044575A1 (en) Compositions and methods for reducing food intake and controlling weight
JP5991573B2 (en) Coated particles
JP2021003024A (en) Sustained release covered food powder aggregate, and method for producing the same
JP2016131501A (en) Coated granular composition
JP2019147831A (en) Misoprostol dispersible tablet
KR101812520B1 (en) Improved pharmaceutical starter pellets
JP7182550B2 (en) Pharmaceutical composition particles, orally disintegrating preparation containing same, and method for producing pharmaceutical composition particles
EP3233060B1 (en) Controlled release of active substances
WO2024080884A1 (en) Pharmaceutical compositions of tretinoin and methods of producing such compositions
NZ729003B2 (en) Formulation comprising particles

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20150302

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20160122

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160202

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160323

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20160722

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160804

R150 Certificate of patent or registration of utility model

Ref document number: 5991573

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250